American Century Companies’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-13,971
| Closed | -$405K | – | 2927 |
|
|
2024
Q2 | $405K | Buy |
13,971
+2,137
| +18% | +$62K | ﹤0.01% | 2515 |
|
|
2024
Q1 | $528K | Buy |
11,834
+4,562
| +63% | +$203K | ﹤0.01% | 2429 |
|
|
2023
Q4 | $282K | Buy |
7,272
+1,224
| +20% | +$47.5K | ﹤0.01% | 2590 |
|
|
2023
Q3 | $178K | Buy |
6,048
+2,042
| +51% | +$60K | ﹤0.01% | 2625 |
|
|
2023
Q2 | $255K | Buy |
4,006
+1,636
| +69% | +$104K | ﹤0.01% | 2453 |
|
|
2023
Q1 | $102K | Buy |
2,370
+388
| +20% | +$16.7K | ﹤0.01% | 2543 |
|
|
2022
Q4 | $138K | Buy |
1,982
+675
| +52% | +$46.8K | ﹤0.01% | 2408 |
|
|
2022
Q3 | $192K | Buy |
+1,307
| New | +$192K | ﹤0.01% | 2234 |
|